References
- Aoki M, Tsuji M, Takeda H, et al. (2006). Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice. Eur J Pharmacol 550:78–83
- Backonja MM. (2002). Use of anticonvulsants for treatment of neuropathic pain. Neurology 59:14–17
- Beltz J, McNeil C, Fisher M. (2008). Investigation of the antihyperalgesic effects of the pomegranate extract ellagic acid. AANA J 76:365–6
- Benedetti MS, Ruty B, Baltes E. (2005). Induction of endogenous pathway by antiepileptics and clinical implications. Fundam Clin Pharmacol 19:511–29
- Bianchi M, Rossoni G, Sacerdote P, et al. (1995). Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol 294:71–4
- Brau ME, Dreimann M, Olschewski A, et al. (2001). Effects of drugs used for neuropathic pain management on tetrodotoxin resistant Na+ currents in rat sensory neurons. Anesthesiology 94:137–44
- Dolatshahi M, Farbood Y, Sarkaki A, et al. (2015). Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease. Iran J Basic Med Sci 18:38–46
- El-Shitany NA, El-Bastawissy EA, El-desoky K. (2014). Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol 19:290–9
- Gainok J, Daniels R, Golembiowski D, et al. (2011). Investigation of the anti-inflammatory, antinociceptive effect of ellagic acid as measured by digital paw pressure via the randall-selitto meter in male sprague-dawley rats. AANA J 79:28–34
- Ghorbanzadeh B, Mansouri MT, Hemmati AA, et al. (2014). Involvement of L-arginine/NO/cGMP/KATP channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test. Pharmacol Biochem Behav 126:116–21
- Girish C, Pradhan SC. (2008). Drug development for liver diseases: Focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol 22:623–32
- Girish C, Raj V, Arya J, Balakrishnan S. (2012). Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol 628:118–25
- Girish C, Raj V, Arya J, Balakrishnan S. (2013). Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice. Eur J Pharmacol 710:49–58
- Jain NK, Kulkarni SK, Singh A. (2001). Differential antinociceptive effect of cyclooxygenase inhibitors in acetic acid-induced chemonociception in mice. Analgesia 5:211–16
- Jensen TS. (2002). Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur J Pain 6:61–8
- Kawaura K, Miki R, Urashima Y, et al. (2011). Tipepidine enhances the antinociceptive-like action of carbamazepine in the acetic acid writhing test. Eur J Pharmacol 651:106–8
- Kehlet H, Dahl JB. (1993) The value of ‘‘multimodal’’ or ‘‘balanced analgesia’’ in postoperative pain treatment. Anesth Analg 77:1048–56
- Le Bars D, Gozariu M, Cadden SW. (2001). Animal models of nociception. Pharmacol Rev 53:597–652
- Mansouri MT, Naghizadeh B, Ghorbanzadeh B. (2014). Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test. Pharmacol Biochem Behav 120:43–9
- Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y. (2013). Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain. Eur J Pharmacol 707:46–53
- Mehlisch DR. (2002). The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc 133:861–71
- Miranda HF, Pinardi G. (2004). Isobolographic analysis of the antinociceptive interactions of clonidine with nonsteroidal anti-inflammatory drugs. Pharmacol Res 50:273–8
- Pinardi G, Prieto JC, Miranda HF. (2005). Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice. Pharmacol Biochem Behav 82:120–4
- Reichter JA, Daughters RS, Rivard R, Simone DA. (2001). Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89:221–7
- Rogerio AP, Fontanari C, Melo MCC, et al. (2006). Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol 58:1265–73
- Santos FA, Jeferson FA, Santos CC, et al. (2005). Antinociceptive effect of leaf essential oil from Croton sonderianus in mice. Life Sci 77:2953–63
- Satyanarayana PS, Jain NK, Singh A, Kulkarni SK. (2004). Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuropsychopharmacol Biol Psychiatry 28:641–9
- Solomon RE, Gebhart GF. (1994). Synergistic antinociceptive interactions among drugs administered to the spinal cord. Anesth Analg 78:1164–72
- Spencer JPE. (2009). Flavonoids and brain health: Multiple effects underpinned by common mechanisms. Genes Nutr 4:243–50
- Stepanovic-Petrovic RM, Tomic MA, Vuckovic SM, et al. (2008). The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth Analg 106:1897–903
- Tallarida RJ. (2001). Drug synergism: Its detection and applications. J Pharmacol Exp Ther 298:865–72
- Tallarida RJ, Stone DJJ, Raffa RB. (1997). Efficient designs for studying synergistic drug combinations. Life Sci 61:417–25
- Ullah MF, Khan MW. (2008). Food as medicine: Potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac J Cancer Prev 9:187–96
- Vucvkovic SM, Tomic MA, Stepanovic-Petrovic RM, et al. (2006). The effects of a2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 125:10–19